On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not

Drug safety evaluation of ziprasidone

(2011) Leslie Citrome   Expert Opinion On Drug Safety

Evidence-based medicine: it’s not just about the evidence

(2011) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Highlights of Drug Package Inserts and the Website DailyMed

(2011) Jose de Leon   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Iloperidone redux: a dissection of the Drug Approval Package for this newly commercialised second-generation antipsychotic

(2010) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed

(2010) Leslie Citrome   POSTGRADUATE MEDICINE

Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making

(2009) Jan Volavka et al.   EXPERT OPINION ON PHARMACOTHERAPY